603658.SS SHH
Autobio Diagnostics Co., Ltd.
1W: -2.5%
1M: +3.5%
3M: +13.0%
YTD: -6.9%
1Y: -16.8%
3Y: -33.9%
5Y: -50.3%
¥34.08 ($5.08)
+0.47 (+1.40%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$1.3B
-10.9% ▼
5Y CAGR: +9.2%
Capital Expenditures
$664M
+26.2% ▲
5Y CAGR: -2.7%
Free Cash Flow
$645M
+13.2% ▲
5Y CAGR: +51.5%
Dividends Paid
$623M
-30.1% ▼
Buybacks
$566M
+0.0% ▲
Net Change in Cash
-$1.0B
-396.3% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $757M | $980M | $1.2B | $1.2B | $1.2B |
| Depreciation & Amort. | $302M | $397M | $433M | $452M | $478M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$133M | $143M | -$51M | -$187M | -$421M |
| Other Non-Cash Items | $69M | -$58M | -$11M | $39M | $53M |
| Operating Cash Flow | $995M | $1.5B | $1.6B | $1.5B | $1.3B |
| — Investing Activities — | |||||
| Capital Expenditures | -$1.1B | -$1.1B | -$938M | -$900M | -$664M |
| Acquisitions (Net) | $26M | $280K | $2M | $0 | -$2M |
| Investment Purchases | -$7.0B | -$2M | -$10M | -$113M | -$56M |
| Investment Sales | $42M | $345M | $7M | $0 | $0 |
| Other Investing | $4.5B | $212M | -$40M | $226M | -$464M |
| Investing Cash Flow | -$3.5B | -$511M | -$979M | -$787M | -$1.2B |
| — Financing Activities — | |||||
| Net Debt Issuance | -$113M | -$97M | -$100M | $537M | -$151M |
| Stock Repurchased | -$56M | -$17M | -$243M | $0 | -$566M |
| Dividends Paid | -$388M | -$383M | -$419M | -$479M | -$623M |
| Other Financing | $3.2B | -$6M | $301M | -$395M | $182M |
| Financing Cash Flow | $2.7B | -$502M | -$218M | -$337M | -$1.2B |
| Net Change in Cash | $191M | $440M | $369M | $349M | -$1.0B |
| Cash End of Period | $328M | $767M | $1.1B | $1.5B | $452M |
| Free Cash Flow | -$121M | $395M | $620M | $569M | $645M |